Close Menu

NEW YORK (GenomeWeb) — OpGen said today that it expects to post a 36 percent drop in its third quarter revenues amid a drop in sales of its QuickFISH rapid pathogen diagnostic products.

For the three months ended Sept. 30, OpGen reported preliminary unaudited revenues of $550,000 versus $750,000 in the same period last year — a decline the Gaithersburg, Maryland-based company attributed to lower QuickFISH revenues.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.